E-LIB Suche - Ergebnisse für: Breeman, Wout A. P.

1

Therapeutic application of CCK2R-targeting PP-F11: influenc..:

Konijnenberg, Mark W. ; Breeman, Wout A. P. ; de Blois, Erik...
EJNMMI Research. 4 (2014) 1 - p. , 2014

2

Comparison of biological stability and metabolism of CCK2 r..:

Ocak, Meltem ; Helbok, Anna ; Rangger, Christine...
European Journal of Nuclear Medicine and Molecular Imaging. 38 (2011) 8 - p. 1426-1435 , 2011

Link: https://doi.org/10.1007/..

3

Androgen‐regulated gastrin‐releasing peptide receptor expre..:

Schroeder, Rogier P.J. ; de Visser, Monique ; van Weerden, Wytske M....
International Journal of Cancer. 126 (2010) 12 - p. 2826-2834 , 2010

Link: https://doi.org/10.1002/..

4

A standardised study to compare prostate cancer targeting e..:

Schroeder, Rogier P. J. ; Müller, Cristina ; Reneman, Suzanne...
European Journal of Nuclear Medicine and Molecular Imaging. 37 (2010) 7 - p. 1386-1396 , 2010

Link: https://doi.org/10.1007/..

5

Comparison of three radiolabelled peptide analogues for CCK..:

Fröberg, Alida C. ; de Jong, Marion ; Nock, Berthold A....
European Journal of Nuclear Medicine and Molecular Imaging. 36 (2009) 8 - p. 1265-1272 , 2009

Link: https://doi.org/10.1007/..

6

Tumor Imaging and Therapy Using Radiolabeled Somatostatin A..:

de Jong, Marion ; Breeman, Wout A. P. ; Kwekkeboom, Dik J...
Accounts of Chemical Research. 42 (2009) 7 - p. 873-880 , 2009

Link: https://doi.org/10.1021/..

7

[99mTc]Demotate 2 in the detection of sst2-positive tumours..:

Maina, Theodosia ; Nock, Berthold A. ; Cordopatis, Paul...
European Journal of Nuclear Medicine and Molecular Imaging. 33 (2006) 7 - p. 831-840 , 2006

Link: https://doi.org/10.1007/..

8

Tyr3-Octreotide and Tyr3-Octreotate Radiolabeled with177Lu ..:

Capello, Astrid ; Krenning, Eric P. ; Breeman, Wout A.P....
Cancer Biotherapy and Radiopharmaceuticals. 18 (2003) 5 - p. 761-768 , 2003

Link: https://doi.org/10.1089/..

9

Phase I study of peptide receptor radionuclide therapy with..:

Valkema, Roelf ; de Jong, Marion ; Bakker, Willem H....
Seminars in Nuclear Medicine. 32 (2002) 2 - p. 110-122 , 2002

Link: https://doi.org/10.1053/..

10

Somatostatin receptor-targeted radionuclide therapy of tumo..:

de Jong, Marion ; Valkema, Roelf ; Jamar, Francois...
Seminars in Nuclear Medicine. 32 (2002) 2 - p. 133-140 , 2002

Link: https://doi.org/10.1053/..

11

[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targ..:

de Jong, Marion ; Breeman, Wout A.P. ; Bernard, Bert F....
International Journal of Cancer. 92 (2001) 5 - p. 628-633 , 2001

Link: https://doi.org/10.1002/..

12

Pre-clinical evaluation of [111In-DTPA-Pro1, Tyr4]bombesin,..:

Breeman, Wout A.P. ; De Jong, Marion ; Bernard, Bert F....
International Journal of Cancer. 83 (1999) 5 - p. 657-663 , 1999

Link: https://doi.org/10.1002/..

13

Evaluation of radiolabelled bombesin analogues for receptor..:

Breeman, Wout A.P. ; Hofland, Leo J. ; de Jong, Marion...
International Journal of Cancer. 81 (1999) 4 - p. 658-665 , 1999

Link: https://doi.org/10.1002/..

14

Tumour uptake of the radiolabelled somatostatin analogue [D..:

de Jong, Marion ; Breeman, Wout A. P. ; Bernard, Bert F....
European Journal of Nuclear Medicine and Molecular Imaging. 26 (1999) 7 - p. 693-698 , 1999

Link: https://doi.org/10.1007/..

15

Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3]..:

De Jong, Marion ; Bakker, Willem H. ; Breeman, Wout A. P....
International Journal of Cancer. 75 (1998) 3 - p. 406-411 , 1998

Link: https://doi.org/10.1002/..